ALGN
ALGN
Align Technology, Inc.Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q1-2026 | $1.04B ▼ | $564M ▲ | $112.77M ▼ | 10.84% ▼ | $1.58 ▼ | $172.67M ▼ |
| Q4-2025 | $1.05B ▲ | $528.55M ▼ | $135.76M ▲ | 12.96% ▲ | $1.89 ▲ | $278.57M ▲ |
| Q3-2025 | $995.69M ▼ | $542.9M ▼ | $56.75M ▼ | 5.7% ▼ | $0.78 ▼ | $152.01M ▼ |
| Q2-2025 | $1.01B ▲ | $545.08M ▼ | $124.61M ▲ | 12.31% ▲ | $1.72 ▲ | $203.61M ▲ |
| Q1-2025 | $979.26M | $549.01M | $93.23M | 9.52% | $1.27 | $174.43M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q1-2026 | $1.06B ▼ | $6.31B ▲ | $2.16B ▼ | $4.15B ▲ |
| Q4-2025 | $1.09B ▲ | $6.23B ▲ | $2.18B ▼ | $4.05B ▲ |
| Q3-2025 | $1B ▲ | $6.23B ▲ | $2.28B ▼ | $3.96B ▲ |
| Q2-2025 | $901.16M ▲ | $6.22B ▲ | $2.31B ▼ | $3.91B ▲ |
| Q1-2025 | $873.01M | $6.1B | $2.31B | $3.79B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q1-2026 | $112.77M ▼ | $151.04M ▼ | $-131.58M ▼ | $-48.13M ▲ | $-35.05M ▼ | $120.26M ▼ |
| Q4-2025 | $135.76M ▲ | $223.18M ▲ | $-35.92M ▼ | $-97.41M ▼ | $90.38M ▼ | $289.71M ▲ |
| Q3-2025 | $56.75M ▲ | $188.72M ▲ | $-19.76M ▲ | $-64.12M ▲ | $103.47M ▲ | $122.19M ▼ |
| Q2-2025 | $-93.23M ▼ | $128.65M ▲ | $-31.48M ▼ | $-96.3M ▲ | $28.27M ▲ | $153.94M ▲ |
| Q1-2025 | $93.23M | $52.68M | $-25.29M | $-206.76M | $-170.89M | $27.39M |
Revenue by Products
| Product | Q1-2024 | Q2-2024 | Q3-2024 | Q4-2024 |
|---|---|---|---|---|
Clear Aligner | $820.00M ▲ | $830.00M ▲ | $790.00M ▼ | $790.00M ▲ |
Scanners And Services | $180.00M ▲ | $200.00M ▲ | $190.00M ▼ | $200.00M ▲ |
Revenue by Geography
| Region | Q2-2025 | Q3-2025 | Q4-2025 | Q1-2026 |
|---|---|---|---|---|
Other International | $350.00M ▲ | $370.00M ▲ | $390.00M ▲ | $390.00M ▲ |
SWITZERLAND | $240.00M ▲ | $210.00M ▼ | $250.00M ▲ | $250.00M ▲ |
UNITED STATES | $420.00M ▲ | $410.00M ▼ | $400.00M ▼ | $400.00M ▲ |
Q1 2026 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Align Technology, Inc.'s financial evolution and strategic trajectory over the past five years.
Align combines a leading brand in clear aligners with a powerful, integrated digital dentistry platform, supported by strong gross margins, net cash, and a conservative balance sheet. Its large installed base of trained professionals, extensive treatment data, and ongoing R&D investment create high switching costs and a durable technological edge. The business consistently generates positive cash flow and retains meaningful financial flexibility despite recent profit pressure.
The main concerns are declining profitability, weaker cash generation than in the past, and a trend of margin compression driven by high operating costs. Slowing growth in retained earnings and reduced capital spending raise questions about the pace of future expansion. Competitive intensity is increasing as alternative clear aligner providers and traditional orthodontic options vie for share, while macro and regulatory factors could further pressure pricing and demand.
Align appears to be in a transition phase: strategically well‑positioned with strong technology and a healthy balance sheet, but adjusting to a more competitive, less explosive growth environment. If its increased R&D and digital ecosystem investments translate into higher case volumes, better mix, or new revenue streams, there is potential for margins and cash flow to improve over time. Until then, the company’s story is one of a high‑quality franchise navigating a period of slower growth and compressed profitability, cushioned by a solid financial foundation.
About Align Technology, Inc.
https://www.aligntech.comAlign Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q1-2026 | $1.04B ▼ | $564M ▲ | $112.77M ▼ | 10.84% ▼ | $1.58 ▼ | $172.67M ▼ |
| Q4-2025 | $1.05B ▲ | $528.55M ▼ | $135.76M ▲ | 12.96% ▲ | $1.89 ▲ | $278.57M ▲ |
| Q3-2025 | $995.69M ▼ | $542.9M ▼ | $56.75M ▼ | 5.7% ▼ | $0.78 ▼ | $152.01M ▼ |
| Q2-2025 | $1.01B ▲ | $545.08M ▼ | $124.61M ▲ | 12.31% ▲ | $1.72 ▲ | $203.61M ▲ |
| Q1-2025 | $979.26M | $549.01M | $93.23M | 9.52% | $1.27 | $174.43M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q1-2026 | $1.06B ▼ | $6.31B ▲ | $2.16B ▼ | $4.15B ▲ |
| Q4-2025 | $1.09B ▲ | $6.23B ▲ | $2.18B ▼ | $4.05B ▲ |
| Q3-2025 | $1B ▲ | $6.23B ▲ | $2.28B ▼ | $3.96B ▲ |
| Q2-2025 | $901.16M ▲ | $6.22B ▲ | $2.31B ▼ | $3.91B ▲ |
| Q1-2025 | $873.01M | $6.1B | $2.31B | $3.79B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q1-2026 | $112.77M ▼ | $151.04M ▼ | $-131.58M ▼ | $-48.13M ▲ | $-35.05M ▼ | $120.26M ▼ |
| Q4-2025 | $135.76M ▲ | $223.18M ▲ | $-35.92M ▼ | $-97.41M ▼ | $90.38M ▼ | $289.71M ▲ |
| Q3-2025 | $56.75M ▲ | $188.72M ▲ | $-19.76M ▲ | $-64.12M ▲ | $103.47M ▲ | $122.19M ▼ |
| Q2-2025 | $-93.23M ▼ | $128.65M ▲ | $-31.48M ▼ | $-96.3M ▲ | $28.27M ▲ | $153.94M ▲ |
| Q1-2025 | $93.23M | $52.68M | $-25.29M | $-206.76M | $-170.89M | $27.39M |
Revenue by Products
| Product | Q1-2024 | Q2-2024 | Q3-2024 | Q4-2024 |
|---|---|---|---|---|
Clear Aligner | $820.00M ▲ | $830.00M ▲ | $790.00M ▼ | $790.00M ▲ |
Scanners And Services | $180.00M ▲ | $200.00M ▲ | $190.00M ▼ | $200.00M ▲ |
Revenue by Geography
| Region | Q2-2025 | Q3-2025 | Q4-2025 | Q1-2026 |
|---|---|---|---|---|
Other International | $350.00M ▲ | $370.00M ▲ | $390.00M ▲ | $390.00M ▲ |
SWITZERLAND | $240.00M ▲ | $210.00M ▼ | $250.00M ▲ | $250.00M ▲ |
UNITED STATES | $420.00M ▲ | $410.00M ▼ | $400.00M ▼ | $400.00M ▲ |
Q1 2026 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Align Technology, Inc.'s financial evolution and strategic trajectory over the past five years.
Align combines a leading brand in clear aligners with a powerful, integrated digital dentistry platform, supported by strong gross margins, net cash, and a conservative balance sheet. Its large installed base of trained professionals, extensive treatment data, and ongoing R&D investment create high switching costs and a durable technological edge. The business consistently generates positive cash flow and retains meaningful financial flexibility despite recent profit pressure.
The main concerns are declining profitability, weaker cash generation than in the past, and a trend of margin compression driven by high operating costs. Slowing growth in retained earnings and reduced capital spending raise questions about the pace of future expansion. Competitive intensity is increasing as alternative clear aligner providers and traditional orthodontic options vie for share, while macro and regulatory factors could further pressure pricing and demand.
Align appears to be in a transition phase: strategically well‑positioned with strong technology and a healthy balance sheet, but adjusting to a more competitive, less explosive growth environment. If its increased R&D and digital ecosystem investments translate into higher case volumes, better mix, or new revenue streams, there is potential for margins and cash flow to improve over time. Until then, the company’s story is one of a high‑quality franchise navigating a period of slower growth and compressed profitability, cushioned by a solid financial foundation.

CEO
Joseph Hogan
Compensation Summary
(Year 2025)
Upcoming Earnings
ETFs Holding This Stock
Summary
Showing Top 3 of 418
Ratings Snapshot
Rating : A-
Most Recent Analyst Grades
Evercore ISI Group
Outperform
Morgan Stanley
Equal Weight
Piper Sandler
Overweight
Barclays
Overweight
HSBC
Buy
Stifel
Buy
Grade Summary
Showing Top 6 of 10
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:8.3M
Value:$1.45B
BLACKROCK INC.
Shares:7.95M
Value:$1.39B
BLACKROCK, INC.
Shares:4.95M
Value:$866.74M
Summary
Showing Top 3 of 1,126

